Skip to content

UK's leading Medical Cannabis Company

Access and care.

Lyphe is UK's most popular cannabis clinical telehealth and dispensing ecosystem.

We own the medical cannabis supply chain vertically.

Digital clinical care
Manufacturing medical cannabis
Pharmacy home delivery direct-to-patients

Our pursuit is for patient access to be mainstream and global.

+130k Cannabis units despatched
+9k Patient consultations
35% UK market share
3x Digital platforms
No.1 Own label cannabis brand
600 Healthcare professionals trained

Our platforms.

Cannabis Prescription Dispensing

Order, track and manage your medical prescriptions.

Learn more

Telehealth Cannabis Care

Clinical services carried out via video consultations.

Learn more

Educating Cannabis Doctors

Advanced medical cannabis training online.

Learn more

Press room.

Lyphe Group secures £5m in funding led by Leafy Tunnel

The UK-based medical cannabis ecosystem provider has received funding from Leafy Tunnel, a venture capital fund investing in European medical cannabis and global medical psychedelics companies. Sharp Capital Advisors, a leading US cannabis advisory firm also participated as an investor in the round. The funds are being used for expansion into multiple markets across Europe … Continued

CEO Jonathan Nadler talks UK Medical Cannabis in The Daily Express

Recently, LYPHE Group CEO and Co-Founder Jonathan Nadler spoke to Christopher Sharp at the Daily Express on medical cannabis, the challenges the industry faces and what the next steps need to be.   “1.4 million people roughly are consuming illegally for medical reasons. There should be a lot more of those patients that have access … Continued
View more

Proud to stock the best medical cannabis brands in the world.


For general enquiries please complete the form.

Lyphe Group

20-22 Wenlock Road,

London, N17GU